Chimeric G250
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Chimeric G250, covering 2018-11-28 to 2018-11-28. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 [Phase 1]